Sequential functional imaging with technetium-99m hexakis-2-meth oxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer?
- 1 February 1995
- journal article
- case report
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 22 (2) , 177-180
- https://doi.org/10.1007/bf00838949
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Somatostatin analogue scintigraphy in granulomatous diseasesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- A cross-linking assay allows the detection of receptors for the somatostatin analogue, lanreotide in human breast tumoursEuropean Journal Of Cancer, 1993
- Chemotherapy of Lung CancerNew England Journal of Medicine, 1992
- Increased accumulation of hexakis (2-methoxyisobutylisonitrile)technetium(I) in osteosarcoma and its metastatic lymph nodes.1991
- Pharmacology of drugs that alter multidrug resistance in cancer.1990
- UPTAKE OF THE CATION HEXAKIS(2-METHOXYISOBUTYLISONITRILE)-TECHNETIUM-99M BY HUMAN CARCINOMA CELL-LINES INVITRO1990
- EFFECT OF METABOLIC INHIBITION ON TECHNETIUM-99M-MIBI KINETICS IN CULTURED CHICK MYOCARDIAL-CELLS1990
- CHARACTERIZATION OF VARIANT SUBCLASSES OF CELL-LINES DERIVED FROM SMALL CELL LUNG-CANCER HAVING DISTINCTIVE BIOCHEMICAL, MORPHOLOGICAL, AND GROWTH-PROPERTIES1985